期刊文献+

结肠癌肝转移患者临床病理因素对预后的影响 被引量:6

The influence of clinicopathologic parameters on prognosis of liver metastasis from colon cancer
下载PDF
导出
摘要 目的:探讨结肠癌肝转移患者行手术治疗的效果以及患者的预后影响因素。方法:选取2010年2月至2015年1月5年间收治的结肠癌肝转移患者为研究对象,所有患者均进行手术治疗,治疗后对患者进行随访调查,观察随访1年、3年间患者的生存率,并且通过单因素分析影响患者预后的相关因素。结果:在120例结肠癌肝转移中,行单纯原发灶肿瘤切除患者1年、3年的生存率为47.87%、11.70%,行原发灶与肝转移灶均切除的患者1年、3年的生存率分别为65.38%、46.15%;单因素分析结果显示,肿瘤分化程度、CEA、肝转移灶切除、介入治疗、全身化疗是影响患者生存率的关键因素。结论:对于结肠癌肝转移患者而言,应尽快的采取手术根治的方法进行治疗,同时后续可采取介入治疗、全身化疗等方法来延长患者的生存周期。 Objective:To investigate the effect ofclinicopathologic parameters on prognosis of liver metastasis from colon cancer.Methods:Patients with colorectal cancer liver metastases from February 2010 to January 2015 were enrolled in this study.All patients underwent surgical treatment.The patients were followed up for 1 year and 3 years.Survival time and the univariate analysis were used to check the prognosis of patients related factors.Results:The 1-year survival rate and 3-year survival rate of patients with primary tumor resection was 47.87%and 11.70%respectively.However,The 1-year survival rate and 3-year survival rate of patientsundergoing primary and liver metastasis tumor resection was 65.38%and 46.15%.The results show that the degree of tumor differentiation,CEA,liver resection,interventional therapy and systemic chemotherapy are important factors forprognosis of patients.Conclusion:Patients with liver metastases of colon cancer should be treated with radical surgery as soon as possible,following with intervention therapy,systemic chemotherapy and other methods to promote the survival time.
作者 孙志德 程利民 SUN Zhide;CHENG Limin(The Affiliated Hospital of Chengde Medical College,Heibei Chengde 067000,China)
出处 《河北医学》 CAS 2019年第7期1151-1154,共4页 Hebei Medicine
关键词 结肠癌肝转移 手术治疗 预后 Colon cancer Liver metastasis Surgical treatment Prognosis
  • 相关文献

参考文献6

二级参考文献29

  • 1王锡山.从ESMO共识看结直肠癌肝转移的治疗策略[J].中华结直肠疾病电子杂志,2014,3(1):9-11. 被引量:9
  • 2黄忠诚,苏冀.结直肠癌肝转移的转化治疗策略[J].中华结直肠疾病电子杂志,2013,2(5):217-220. 被引量:4
  • 3刘宇军,王国民,张永康,张立,孙立安,林宗明,朱同玉.肾上腺转移性肿瘤103例分析[J].中华外科杂志,2007,45(2):124-127. 被引量:9
  • 4庞典付,龚腊梅,冯安明,张克难.结直肠癌复发再手术60例报告[J].中国普通外科杂志,2007,16(9):849-851. 被引量:5
  • 5张丽梅,郑伟,胡晓东,宋少柏.结肠癌右肾上腺转移1例[J]军医进修学院学报,1999(02).
  • 6Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CACancer J Clin, 2011, 61(2): 69-90.
  • 7West NP, Hohenberger W, Weber K, et al. Complete mesocolicexcision with central vascular ligation produces an oncologicallysuperior specimen compared with standard surgery for carcinoma ofthe colon[J]. J Clin Oncol, 2010, 28(10): 272-278.
  • 8Lee J, Lim do H, Kim S, et al. Phase Ⅲ trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrentcapecitabine radiotherapy in completely resected gastric cancer withD2 lymph node dissection: the ARTIST trial[J]. J Clin Oncol, 2012,30(3): 268-273.
  • 9Renzulli P, Lowy A, Maibach R, et al. The influence of the surgeonsand the hospitals caseload on survival and local recurrence aftercolorectal cancer surgery[J]. Surgery, 2006, 139(3): 296-304.
  • 10De la Cruz-Merino L, Henao Carrasco F, Vicente Baz D, et al.Immune microenvironment in colorectal cancer: a new hallmark tochange old paradigms[J]. Clin Dev Immunol, 2011(2011): 174149.

共引文献116

同被引文献60

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部